Trials / Recruiting
RecruitingNCT07227077
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
An Adaptive Design for Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Medical College of Wisconsin · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity.
Detailed description
The primary objective of this study is to test a theory-based, micro-randomized trial to determine the optimal state to deliver a message to increase physical activity by determining the probability older cancer survivors will be physically active in the one hour following a messaging prompt. The secondary, exploratory objective is to determine the probability older cancer survivors will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity. Eligibility criteria is deliberately incomplete to preserve the scientific integrity of the study.
Conditions
- Breast Cancer
- Cervical Cancer
- Bladder Cancer
- Colorectal Cancer
- Endometrial Cancer
- Lung Cancer
- Prostate Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Physical Activity Promotion Intervention | This physical activity promotion intervention is a micro-randomized trial designed to determine the most effective time to send a message to promote physical activity among cancer survivors who experience chronic pain symptoms. |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2027-05-01
- Completion
- 2027-05-01
- First posted
- 2025-11-12
- Last updated
- 2026-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07227077. Inclusion in this directory is not an endorsement.